Wang et al and Raspollini et al reported interesting data in the management of thyroid and uterus leiomyosarcomas through the overexpression of c-Kit proto-oncogene, a tyrosine kinase receptor [4, 12]. The gene discussed is NTRK1; the disease is leiomyosarcoma.